Patients with MGMT promoter methylation and IDH1 mutation are associated with increased progression-free and overall survival.[42, 43] Here, by performing multivariable Cox regression analysis, we showed that the radiosensitivity gene signature is independent of these possible prognostic predictors(when available) among patients of glioma treated with radiotherapy. Here, MGMT is linked to central nervous system cancer.